GZMB and neoplasm: Two NKT subsets have been identified: type I induce the lysis of tumor cells directly via a perforin/granzyme B-mediated mechanism or indirectly via the activation of NK cells and DCs; type II show immunosuppressive activity through the production of IL-13 [194].